| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/18/2006 | US20060105034 Formulation and delivery method to enhance antioxidant potency of Vitamin E |
| 05/18/2006 | US20060105023 Treatment of neurological disorders with nicotine |
| 05/18/2006 | US20060105022 Process for preparing crosslinked hyaluronic acid gel |
| 05/18/2006 | US20060105021 Cholesterol-reducing liquid |
| 05/18/2006 | US20060105020 Highly absorbable taste and odor free organic nutritional supplement made from food by products and mixable with solids and liquids, and method of making such |
| 05/18/2006 | US20060105001 drugs specifically bound to synthetic receptors in such a manner that active drug becomes available only in the presence of a targeted pathophysiologic receptor; increasing efficacy and safety, while reducing side effects |
| 05/18/2006 | US20060104999 Composition for solubilization of paclitaxel and preparation method thereof |
| 05/18/2006 | US20060104970 Biological glue based on thrombin-conjugated nanoparticles |
| 05/18/2006 | US20060104966 Transglutaminase linkage of agents to tissue |
| 05/18/2006 | US20060104956 gene expression inhibition; hairpin nucleic acids; for treatment of viral infections, tumors, and cancer |
| 05/18/2006 | US20060104942 Anticholesterol agents; anticholesterol agents; cardiovascular disorders; mixture of colony stimulating factor and hepatocyte growth factor |
| 05/18/2006 | US20060104912 Mousse composition |
| 05/18/2006 | US20060104909 Abuse-resistant pharmaceutical compositions |
| 05/18/2006 | US20060103807 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 05/18/2006 | DE3830494B4 Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe Water-soluble mono esters as solubilizers for pharmacologically active substances and pharmaceutical excipients |
| 05/18/2006 | DE10156794B4 Arzneimittel zur Behandlung von Warzen Medicines used to treat warts |
| 05/18/2006 | CA2587369A1 Mutant interferon .alpha. proteins and use thereof |
| 05/18/2006 | CA2586811A1 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 05/18/2006 | CA2586798A1 Retinoid solutions and formulations made therefrom |
| 05/18/2006 | CA2586771A1 Stable formulations of insulinoptropic peptides |
| 05/18/2006 | CA2586354A1 Liposome formulation of peptide boronic acids compounds |
| 05/18/2006 | CA2586348A1 Liposomal formulation of bortezomib (ps-341) |
| 05/18/2006 | CA2585976A1 Novel composition for easing human childbirth |
| 05/18/2006 | CA2585927A1 Polypeptides that bind baff and/or april |
| 05/18/2006 | CA2585421A1 Conjugates with enhanced cell uptake activity |
| 05/18/2006 | CA2585296A1 Stabilized freeze-dried formulation for cephalosporin derivatives |
| 05/18/2006 | CA2584017A1 Aqueous ophthalmic suspension of crystalline rebamipide |
| 05/17/2006 | EP1657263A1 Polymer sustainedly releasing amino acid derivative, cosmetic and fiber construct containing the polymer, method of producing the same and method of regenerating the same |
| 05/17/2006 | EP1656952A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 05/17/2006 | EP1656951A1 Conjugates with enhanced cell uptake activity |
| 05/17/2006 | EP1656950A1 Immunotoxins directed against CD33 related surface antigens |
| 05/17/2006 | EP1656930A1 Stabilized freeze-dried formulation for cephalosporin derivatives |
| 05/17/2006 | EP1656410A2 Method for preparing functionalized polymers from polymer alcohols |
| 05/17/2006 | EP1656159A2 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 05/17/2006 | EP1656158A2 Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
| 05/17/2006 | EP1656149A1 Sealing of bacterial ghosts by means of bioaffinity interactions |
| 05/17/2006 | EP1656125A2 Topical composition comprising terbinafine and hydrocortisone |
| 05/17/2006 | EP1656116A2 Polymeric systems for controlled drug therapy |
| 05/17/2006 | EP1656113A2 Method for the production of effervescent granules in a vacuum |
| 05/17/2006 | EP1656018A1 Edible films for administration of medicaments to animals |
| 05/17/2006 | EP1507755A4 Novel monofunctional polyethylene glycol aldehydes |
| 05/17/2006 | EP1507519B1 Medicament with delayed release of the active substance, containing 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol |
| 05/17/2006 | EP1372611B1 Pharmaceutical composition comprising a poorly water-soluble staurosporine, a surfactant and a water-soluble polymer |
| 05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 05/17/2006 | EP1268609B1 Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 05/17/2006 | EP1253903B1 Surfactant free topical compositions and method for rapid preparation thereof |
| 05/17/2006 | EP1197221B1 G-csf preparations stabilized over long time |
| 05/17/2006 | EP1141235B1 (bifidobacterium) in the treatment of inflammatory disease |
| 05/17/2006 | EP1115372B1 Fast dissolving orally consumable films |
| 05/17/2006 | EP1012563A4 Breath test for detection of drug metabolism |
| 05/17/2006 | EP1007729A4 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 05/17/2006 | EP1007101B1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/17/2006 | EP0938900B1 Preventives/remedies for stomatitis |
| 05/17/2006 | EP0716610B1 Human bone morphogenetic proteins for use in neural regeneration |
| 05/17/2006 | CN1774444A Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/17/2006 | CN1774414A New non-ionic surfactants for solubilizing poorly soluble molecules |
| 05/17/2006 | CN1774266A Liquid formulations of tumor necrosis factor-binding proteins. |
| 05/17/2006 | CN1774263A Long acting injectable insulin composition and methods of making and using thereof |
| 05/17/2006 | CN1774259A Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 05/17/2006 | CN1774254A Phosphate derivatives of pharmaceutical products |
| 05/17/2006 | CN1774237A Angiogenesis promotion by prostaglandin compositions and methods |
| 05/17/2006 | CN1772782A Amphipatic fluorescent polymer and its prepn and use |
| 05/17/2006 | CN1772303A Nanometer magnetic powder-antibody targeting medicine for magneto thermical threrapy of malignant tumor |
| 05/17/2006 | CN1772302A Heat resistant freeze drying protectant for chicken Newcastle disease live vaccine and its prepn and application |
| 05/17/2006 | CN1772301A Nimodipine soft capsule and its prepn |
| 05/17/2006 | CN1772300A Nanometer manetic powder for magnetothermical therapy and anti-CEA antibody target medicine |
| 05/17/2006 | CN1771980A Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
| 05/17/2006 | CN1771913A Emulifying solvent diffusing process for preparing taste masked micro ball |
| 05/17/2006 | CN1256146C Aqueous formulations of LHRH related peptide compound and preparing method and use thereof |
| 05/17/2006 | CN1256092C Methyleritrocina injection |
| 05/17/2006 | CN1256082C Slow-released preparation |
| 05/17/2006 | CN1256080C In-situ gel formation of pectins |
| 05/16/2006 | US7045617 Bisbubstrate inhibitors of kinases |
| 05/16/2006 | US7045605 genetic engineered antibodies, nucleic acids; anticancer agents |
| 05/16/2006 | US7045601 Complexing with metal compound and complexing agent |
| 05/16/2006 | US7045589 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 05/16/2006 | US7045585 Methods of coating a device using anti-thrombin heparin |
| 05/16/2006 | US7045576 Adjuvants and copolymer compositions |
| 05/16/2006 | US7045559 Skin contact adhesives; electricity interface for disposable medical devices; shelf life; storage stability; protective coatings |
| 05/16/2006 | US7045552 Aqueous formulation of fusion inhibitor and polyol; minimizes number of injections and site reaction |
| 05/16/2006 | US7045499 Therapeutic agent |
| 05/16/2006 | US7045494 Adjustment of pH; purification using ion exchange resin; controlling viscosity and temperature |
| 05/16/2006 | US7045283 Detecting preferential ligands in cell; obtain cell, incubate with reporter molecules, detect reporter in cell |
| 05/16/2006 | US7045147 Therapy for congestive heart failure; administering by mouth |
| 05/16/2006 | US7045146 Treating the solid particle material with an amphiphilic substance and coating the material with a layer of a charged polyelectrolyte or with a multilayer comprising alternating layers of oppositely charged polyelectrolytes. |
| 05/16/2006 | US7045145 Multilayer; backing layer, solid absorption adhesive polymer matrix ; controlled dosage of estrogen and progestin |
| 05/16/2006 | US7045144 Plaster containing an active agent |
| 05/16/2006 | US7045143 Mixture of lecithin and fatty acid; antiinflammatory agents; diseases of lipid metabolism; immunology disorders |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/16/2006 | US7045134 Borellia burgdorferi epitope peptides |
| 05/16/2006 | US7045121 Ophthalmic compositions for lubricating eyes and methods for making and using same |
| 05/16/2006 | US7045118 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/16/2006 | US7045095 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 05/16/2006 | CA2366856C Formulation comprising testosteron undecanoate and castor oil |
| 05/16/2006 | CA2291274C Uses of oil bodies |
| 05/11/2006 | WO2006050165A2 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 05/11/2006 | WO2006050101A1 Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
| 05/11/2006 | WO2006049978A1 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption |
| 05/11/2006 | WO2006049855A1 End-capped poly(ester amide) copolymers |
| 05/11/2006 | WO2006049696A1 Novel pigments for wrinkle-hiding cosmetic applications |